Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 1.37 · gapped above the open, then crossed back over prior close. High/low 1.41 at 9:30 am ET, 1.36 at 3:00 pm ET.
Aldeyra Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
107 institutional managers report a position in Aldeyra Therapeutics, Inc. worth $79.2M between them, filed on form 13F for the quarter ending 2026-06-30. 19 of them hold 80% of it, the largest being Knoll Capital Management, LP at 14.72%.
82 more managers in the register
19 managers hold 80% of the $79.2M institutional base. The other 88 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 77 days old and does not move with the price above it.
via Knoll Capital Management, LP, Caption Management, LLC · 14.72% of ALDX, 20.94% of ELTX
via Knoll Capital Management, LP · 14.72% of ALDX, 55.17% of ENTX
via Marshall Wace LLP, Acadian Asset Management LLC, Qube Research & Technologies Ltd +5 more · 4.05% of ALDX, 3.73% of ASYS
via Acadian Asset Management LLC, Marshall Wace LLP, Qube Research & Technologies Ltd +3 more · 2.86% of ALDX, 3.03% of CTRN
via Marshall Wace LLP, Acadian Asset Management LLC, Qube Research & Technologies Ltd +4 more · 4.05% of ALDX, 7.71% of MX
via Marshall Wace LLP, Acadian Asset Management LLC, Qube Research & Technologies Ltd +4 more · 4.05% of ALDX, 4.56% of CRNT
Managers holding a meaningful stake in ALDX also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.
ALDX (Aldeyra Therapeutics, Inc.) has 1 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: ABBV +0.34%, in healthcare.